fbpx

Current enrolling clinical trials

Our clinical trials program is bringing the world’s best treatments to patients with eye diseases.

Current enrolling clinical trials

The Queensland Eye Institute is currently involved in recruitment of the following clinical trials:

AMBLYOPTICA

Protocol Number: SH03050
Phase: Investigational
Sponsor: Amblyoptica (Holding)
Information: Trial of the amblyoptica device for binocular treatment of amblyopia

DELTA

Protocol Number: IDEV-121-DELT
Phase: Investigational
Sponsor: Johnson & Johnson Surgical Vision
Information: Clinical handleability and acceptability assessment of the DELTA disposable delivery system

OTX-TKI

Protocol Number: CLIN-Protocol-0046
Phase: I
Sponsor: Ocular Therapeutix
Information: A phase 1 open-label, dose escalation study of OTX-TKI (axitinib implant) for intravitreal use in subjects with neovascular age-related macular degeneration

COVID-19 UPDATE

Here at QEI & SBDH, the health and safety of our patients and staff is of the highest priority. That's why we are taking measures to prevent the spread of COVID-19 (Coronavirus).

We kindly ask all patients and visitors of the clinic to not enter the building if they are feeling unwell (fever, cough, sore throat or flu symptoms), have been overseas in the last two weeks or have been in contact with a known case of COVID-19.

Please contact us on 07 3239 5000 to reschedule your appointment if this applies to you. Our clinic staff are taking extra precautions through the use of face masks and extra santising measures. We would like to thank all patients and visitors for their cooperation and understanding at this time.